Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy

Administered By

Medicine, Medical Oncology

Awarded By

National Institutes of Health

Contributors

Chan, Francis Ka-Ming Collaborator
Hanks, Brent A. Principal Investigator
Jung, Sin-Ho Biostatistician

Start/End

August 1, 2020 - July 31, 2025